Navigation Links
FIRMAGON® Results in Fast, Long-Term Suppression of Testosterone in Prostate Cancer Patients Without Initial Testosterone Surge
Date:6/1/2010

RMAGON® was shown to be non - inferior to leuprolide in sustaining castrate levels of testosterone from Days 28 – 364. This trial formed the primary basis for the successful Food and Drug Administration (FDA) approval of FIRMAGON® in December, 2008.  The study results showed that at day 3 of treatment, 96% of FIRMAGON® patients achieved castrate levels of testosterone, compared with zero percent receiving leuprolide. The median testosterone level with FIRMAGON® treatment was sustained at <9 ng/dL with no initial testosterone surge or microsurge following maintenance injections throughout the one-year study.

More About FIRMAGON

FIRMAGON is administered monthly by subcutaneous injection.  The starting dose is 240 mg, followed by monthly maintenance doses of 80 mg.  FIRMAGON is available for order through traditional and specialty pharmacy distributors.  The average monthly cost of one year of FIRMAGON treatment is comparable to other hormone treatments for prostate cancer.

Important Safety Information

FIRMAGON is contraindicated in patients with known hypersensitivity to degarelix or to any of the product components.  FIRMAGON is not indicated in women or pediatric patients.  Long-term androgen deprivation therapy prolongs the QT interval.  Physicians should consider whether the benefits of ADT outweigh the potential risks in patients with congenital long QT syndrome, electrolyte abnormalities, or congestive heart failure and in patients taking Class IA (e.g. quinidine, procainamide) or Class III (e.g. amiodarone, sotalol) antiarrhythmic medications. The most commonly observed adverse reactions during FIRMAGON therapy included injection site reactions (e.g. pain, erythema, swelling or induration), hot flashes, increased weight, fatigue, and increases in serum level
'/>"/>

SOURCE Ferring Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Extension Study With FIRMAGON® (degarelix) Showed Continued Benefits for Prostate Cancer Patients Beyond One Year
2. Cantel Medical Corp. to Hold Conference Call to Discuss Results for Its Third Quarter Ended April 30, 2010
3. Elbit Imaging Ltd. Announces First Quarter Results for 2010
4. The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbotts Carotid Stent System and Surgery
5. Abbotts Groundbreaking Bioresorbable Technology Continues to Demonstrate Exceptional Clinical Results
6. Abbotts Investigational MitraClip(R) System Demonstrates Strong Safety Results and Improved Clinical Outcomes for Common Causes of Leaky Heart Valves
7. AcelRx Announces Positive Phase 2 Results From a Study of ARX-02 Sufentanil NanoTab(TM) Breakthrough Pain Management System in Treating Cancer Breakthrough Pain
8. China Yongxin Pharmaceuticals Reports First Quarter 2010 Financial Results
9. Bayer HealthCare Pharmaceuticals, Inc. Announces Results of a Phase 3 Clinical Trial of Gadobutrol
10. Concord Medical to Report First Quarter 2010 Financial Results on Thursday, May 27, 2010
11. China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... , July 10, 2014   Ventana Medical Systems, ... announced it has entered into an agreement with Merck ... as EMD Serono in the United States ... collaborate with Merck KGaA,s biopharmaceutical division on the development ... undisclosed target using Ventana,s proprietary diagnostic assays. In alignment ...
(Date:1/15/2014)... Sono-Tek Corporation (OTC BB: SOTK) today announced sales of  $2,650,000 ... sales of $2,202,000 for the prior year period, an increase ... shown growth over the preceding quarter,s sales, continuing a trend ... Markets that experienced sales increases over the prior year were ...
(Date:1/15/2014)... , Jan. 15, 2014 AARP Foundation today announced ... older adults suffering from the severe cold weather that has ... committed to helping those in need; so to support these ... contributions up to $250,000, which could mean up to $500,000 ...
Breaking Medicine Technology:Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3
... PITTSBURGH, Sept. 21 Mylan Inc. (Nasdaq: ... Inc. has received final approval from the U.S. Food ... Application (ANDA) for Tacrolimus Capsules, 0.5 mg, 1 mg ... Capsules, a treatment to prevent rejection in people who ...
... 20 Data from the GRACE ( G ender, ... xperience) study will be published in the September 21st issue ... the largest-ever study of treatment-experienced adult women with HIV-1 to ... Tibotec Therapeutics Clinical Affairs, a division of Centocor Ortho Biotech ...
Cached Medicine Technology:Data From Landmark Study Evaluating Gender Differences in Response to an HIV Therapy Published in Annals of Internal Medicine 2Data From Landmark Study Evaluating Gender Differences in Response to an HIV Therapy Published in Annals of Internal Medicine 3Data From Landmark Study Evaluating Gender Differences in Response to an HIV Therapy Published in Annals of Internal Medicine 4Data From Landmark Study Evaluating Gender Differences in Response to an HIV Therapy Published in Annals of Internal Medicine 5Data From Landmark Study Evaluating Gender Differences in Response to an HIV Therapy Published in Annals of Internal Medicine 6Data From Landmark Study Evaluating Gender Differences in Response to an HIV Therapy Published in Annals of Internal Medicine 7Data From Landmark Study Evaluating Gender Differences in Response to an HIV Therapy Published in Annals of Internal Medicine 8
(Date:7/11/2014)... Recently, Fadhits.com, the distinguished wedding dress manufacturer and ... dresses . To bring more benefits to worldwide clients in ... special offer for these brand new items. Clients can enjoy ... sales manager says gladly, “We are happy to announce such ... acknowledge all new and old customers and strengthen our relationship ...
(Date:7/11/2014)... revealed that people who have grown up on a ... their urban counterparts to develop the most common inflammatory ... findings have recently been published in the European ... that we can now see that not only allergic ... depend on the environment we are exposed to early ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Recently, iFitDress.com, ... special occasion outfits, has released its new collection of ... that, the company has announced that all these beautiful ... off. The deadline of the special offer is July ... its major officials pay close attention to customer satisfaction. ...
(Date:7/11/2014)... Angeles, CA (PRWEB) July 11, 2014 ... Sands today announces that he uses mini and full ... treatments offer the defining feature that distinguishes dental implants ... teeth in addition to the crowns. This alone prevents ... implants also offer advantages related to comfort, appearance ...
(Date:7/11/2014)... By Maureen Salamon ... (HealthDay News) -- For the millions of women who ... researchers are testing a treatment that uses stem cells ... pilot study, European researchers found that injecting stem cells ... stress incontinence in all participants within a year. ...
Breaking Medicine News(10 mins):Health News:Promotion for Kids Prom Dresses Now Provided at Fadhits.com 2Health News:Growing up on a livestock farm halves the risk of inflammatory bowel diseases 2Health News:Worldwide Chic Ladies Can Buy Cheap Evening Dresses at iFitDress.com 2Health News:Dental Implant Dentist, Kevin Sands DDS, Now Uses Mini and Full Mouth Implants to Replace Missing Teeth 2Health News:Stem Cells May Ease Urinary Incontinence, Study Says 2Health News:Stem Cells May Ease Urinary Incontinence, Study Says 3
... /Xinhua-PRNewswire-FirstCall/ -- China Sky One,Medical, Inc. ("China Sky ... ), a,leading fully integrated pharmaceutical company producing over-the-counter,drugs ... announced record,financial results for the third quarter ended ... Highlights:, -- Total revenues increased 77.1% to ...
... president of,the American Veterinary Medical Association (AVMA), says he ... have become sick due to,holiday excesses., "From Thanksgiving ... year at my practice, and, unfortunately, some of them ... their pets in the,holiday celebrations, but people need to ...
... One in Four Smokers Stressed About State of Economy ... Today the American,Legacy Foundation(R) -- the nation,s largest public ... -- announced the results of a,new survey conducted on ... the ongoing financial downturn is having a clear and ...
... aging individuals in the population mix, coupled with increasing patient demand ... market to over $52.1 billion by the year 2012. Growth will ... new therapeutic applications such as neutropenia prevention and treatment. , ... ...
... Eclipse plug-in, improve HP OpenVMS productivity without specialized skills , ... ... leader in legacy systems evolution, today announced new additions to its ... the HP OpenVMS platform., , ,The products, marketed jointly as NXTware ...
... Association of Health Services Executives (NAHSE) would like to congratulate President-elect ... ... Washington, DC (PRWEB) November 10, 2008 -- The National ... President-elect Barack Obama on his inspirational and historic win. NAHSE ...
Cached Medicine News:Health News:China Sky One Medical, Inc. Announces Record Third Quarter 2008 Results 2Health News:China Sky One Medical, Inc. Announces Record Third Quarter 2008 Results 3Health News:China Sky One Medical, Inc. Announces Record Third Quarter 2008 Results 4Health News:China Sky One Medical, Inc. Announces Record Third Quarter 2008 Results 5Health News:China Sky One Medical, Inc. Announces Record Third Quarter 2008 Results 6Health News:China Sky One Medical, Inc. Announces Record Third Quarter 2008 Results 7Health News:China Sky One Medical, Inc. Announces Record Third Quarter 2008 Results 8Health News:China Sky One Medical, Inc. Announces Record Third Quarter 2008 Results 9Health News:China Sky One Medical, Inc. Announces Record Third Quarter 2008 Results 10Health News:China Sky One Medical, Inc. Announces Record Third Quarter 2008 Results 11Health News:China Sky One Medical, Inc. Announces Record Third Quarter 2008 Results 12Health News:China Sky One Medical, Inc. Announces Record Third Quarter 2008 Results 13Health News:AVMA's Top Ten List on Holiday Pet Health 2Health News:Current Economic Situation Prompts Increased Smoking, Delay in Quit Attempts, Middle and Low-Income Americans Hit Hardest 2Health News:Current Economic Situation Prompts Increased Smoking, Delay in Quit Attempts, Middle and Low-Income Americans Hit Hardest 3Health News:Current Economic Situation Prompts Increased Smoking, Delay in Quit Attempts, Middle and Low-Income Americans Hit Hardest 4Health News:Current Economic Situation Prompts Increased Smoking, Delay in Quit Attempts, Middle and Low-Income Americans Hit Hardest 5Health News:Current Economic Situation Prompts Increased Smoking, Delay in Quit Attempts, Middle and Low-Income Americans Hit Hardest 6Health News:Global Growth Factors (Blood and Tissue) Market to Reach $52.1 Billion by 2012, According to New Report by Global Industry Analysts 2Health News:Global Growth Factors (Blood and Tissue) Market to Reach $52.1 Billion by 2012, According to New Report by Global Industry Analysts 3Health News:Global Growth Factors (Blood and Tissue) Market to Reach $52.1 Billion by 2012, According to New Report by Global Industry Analysts 4Health News:eCube Systems Brings Remote Eclipse Development to HP OpenVMS 2Health News:eCube Systems Brings Remote Eclipse Development to HP OpenVMS 3Health News:The National Association of Health Services Executives (NAHSE) Congratulates President-Elect Barack Obama on Historic Win 2Health News:The National Association of Health Services Executives (NAHSE) Congratulates President-Elect Barack Obama on Historic Win 3
... Medical Professional Diagnostics is a leading provider ... and DFA test menu that includes kits ... as well as miscellaneous conjugates and components. ... a wide assortment of substrates and kit ...
... Medical Professional Diagnostics is a leading provider ... and DFA test menu that includes kits ... as well as miscellaneous conjugates and components. ... a wide assortment of substrates and kit ...
... Medical Professional Diagnostics is a leading provider ... and DFA test menu that includes kits ... as well as miscellaneous conjugates and components. ... a wide assortment of substrates and kit ...
... Inverness Medical Professional Diagnostics is a leading ... IFA and DFA test menu that includes ... STDs as well as miscellaneous conjugates and ... you a wide assortment of substrates and ...
Medicine Products: